AA
RCUS icon

ALPS Advisors’s Arcus Biosciences RCUS Stock Holding History

ALPS Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52,624
Closed -$716K – 1073
2025
Q3 		$716K Sell
52,624
-4,462
-8% -$46.4K ﹤0.01% 619
2025
Q2 		$465K Sell
57,086
-20,021
-26% -$171K ﹤0.01% 652
2025
Q1 		$605K Buy
77,107
+3,112
+4% +$36.1K ﹤0.01% 568
2024
Q4 		$1.1M Buy
73,995
+5,633
+8% +$92K 0.01% 462
2024
Q3 		$1.05M Sell
68,362
-2,586
-4% -$40.8K 0.01% 482
2024
Q2 		$1.08M Buy
70,948
+6,858
+11% +$111K 0.01% 449
2024
Q1 		$1.21M Buy
64,090
+11,619
+22% +$201K 0.01% 429
2023
Q4 		$1M Sell
52,471
-2,480
-5% -$39.6K 0.01% 483
2023
Q3 		$986K Buy
54,951
+1,214
+2% +$24.4K 0.01% 451
2023
Q2 		$1.09M Buy
53,737
+5,637
+12% +$107K 0.01% 472
2023
Q1 		$877K Sell
48,100
-675
-1% -$12.9K 0.01% 495
2022
Q4 		$1.01M Buy
48,775
+9,400
+24% +$259K 0.01% 480
2022
Q3 		$1.03M Sell
39,375
-3,174
-7% -$83.9K 0.01% 460
2022
Q2 		$1.08M Sell
42,549
-30,491
-42% -$747K 0.01% 463
2022
Q1 		$2.31M Sell
73,040
-8,255
-10% -$277K 0.03% 188
2021
Q4 		$3.29M Sell
81,295
-6,208
-7% -$241K 0.04% 184
2021
Q3 		$3.05M Sell
87,503
-6,003
-6% -$187K 0.03% 219
2021
Q2 		$2.57M Sell
93,506
-23,945
-20% -$684K 0.02% 251
2021
Q1 		$3.3M Buy
117,451
+133
+0.1% +$4.63K 0.03% 206
2020
Q4 		$3.05M Buy
+117,318
New +$2.84M 0.03% 214

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ALPS Advisors's RCUS Position: Q4 2025 in Review

ALPS Advisors sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 52,624 shares — an estimated $716K sold.

ALPS Advisors first reported a position in RCUS in Q4 2020 and held it in 20 quarters. The position peaked at $3.3M in Q1 2021. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • ALPS Advisors reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
  • ALPS Advisors sold 52,624 Arcus Biosciences shares in Q4 2025, an estimated $716K.
  • ALPS Advisors first reported a position in Arcus Biosciences in Q4 2020 and held it in 20 quarters.
  • ALPS Advisors's Arcus Biosciences position peaked at $3.3M in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on ALPS Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.